【24h】

Central vein stenosis

机译:中央静脉狭窄

获取原文
获取原文并翻译 | 示例
       

摘要

Central vein stenosis (CVS) is commonly seen in patients receiving hemodialysis through an arteriovenous access, threatening the usability of arteriovenous access for dialysis. Subclavian and internal jugular catheters are prime reasons for the development of CVS, especially in the setting of long-term use of multiple catheters. CVS related to cardiac rhythm devices also is seen frequently. Idiopathic CVS can be encountered, although it is less common. Clinical features ultimately become sufficiently prominent to prompt angiographic evaluation. CVS should be evaluated carefully because management must be individualized. The primary method for treatment of CVS is endovascular intervention, including angioplasty and stent placement, whereas surgical options should be pursued in only refractory cases due to the invasiveness of the intervention. Early referral of patients for chronic kidney disease care; timely discussion of kidney replacement modality choices, including nonhemodialysis options such as peritoneal dialysis and kidney transplantation; placement of arteriovenous access prior to the onset of dialysis; and avoidance of catheters and other central vein instrumentation will prevent the development of CVS in most patients with kidney disease.
机译:在通过动静脉通路接受血液透析的患者中,常见中枢静脉狭窄(CVS),这威胁到动静脉通路用于透析的可用性。锁骨下和颈内导管是发展CVS的主要原因,尤其是在长期使用多个导管的情况下。与心律装置有关的CVS也很常见。尽管不太常见,但可以遇到特发性CVS。临床特征最终变得足够突出,可以迅速进行血管造影评估。应谨慎评估CVS,因为管理必须个性化。治疗CVS的主要方法是血管内干预,包括血管成形术和支架置入,而由于介入的侵入性,仅在难治性病例中才应进行手术选择。尽早转诊患者以治疗慢性肾脏病;及时讨论肾脏替代方式的选择,包括非血液透析选择,如腹膜透析和肾脏移植;在透析开始之前放置动静脉通路;避免使用导管和其他中枢静脉器械将防止大多数肾脏疾病患者发生CVS。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号